Login to Your Account

Financings Roundup

Antibiotic Developer Tetraphase Prices Initial Public Offering

By Peter Winter
BioWorld Insight Editor

Wednesday, March 20, 2013

Antibiotic drug developer Tetraphase Pharmaceuticals Inc., of Watertown, Mass., joined recent publicly listed antibiotic-focused biotechnology companies Trius Therapeutics Inc. (2010) and Cempra Inc. (2012) by pricing its initial public offering (IPO) Wednesday. 

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription